vs
NEKTAR THERAPEUTICS（NKTR）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是NEKTAR THERAPEUTICS的1.5倍（$32.3M vs $21.8M），RBB Bancorp净利率更高（31.5% vs -165.4%，领先196.9%），RBB Bancorp同比增速更快（12.6% vs -25.3%），RBB Bancorp自由现金流更多（$42.6M vs $-65.0M），过去两年RBB Bancorp的营收复合增速更高（7.0% vs 0.4%）
内克塔医疗是一家美国生物制药企业，1990年成立，总部位于加利福尼亚州旧金山。该企业依托专有的聚乙二醇化技术与先进高分子偶联技术，通过改性物质化学结构研发候选新药，可改善药物滞留性、溶解度等特性，同时也是安进、默克、辉瑞等多家知名药企的技术供应商。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
NKTR vs RBB — 直观对比
营收规模更大
RBB
是对方的1.5倍
$21.8M
营收增速更快
RBB
高出37.8%
-25.3%
净利率更高
RBB
高出196.9%
-165.4%
自由现金流更多
RBB
多$107.6M
$-65.0M
两年增速更快
RBB
近两年复合增速
0.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.8M | $32.3M |
| 净利润 | $-36.1M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | -126.9% | 39.5% |
| 净利率 | -165.4% | 31.5% |
| 营收同比 | -25.3% | 12.6% |
| 净利润同比 | -596.9% | 132.1% |
| 每股收益（稀释后） | $-4.67 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NKTRRBB
| Q4 25 | $21.8M | $32.3M | ||
| Q3 25 | $11.8M | $32.6M | ||
| Q2 25 | $11.2M | $35.8M | ||
| Q1 25 | $10.5M | $28.5M | ||
| Q4 24 | $29.2M | $28.7M | ||
| Q3 24 | $24.1M | $30.3M | ||
| Q2 24 | $23.5M | $27.5M | ||
| Q1 24 | $21.6M | $28.2M |
净利润NKTRRBB
| Q4 25 | $-36.1M | $10.2M | ||
| Q3 25 | $-35.5M | $10.1M | ||
| Q2 25 | $-41.6M | $9.3M | ||
| Q1 25 | $-50.9M | $2.3M | ||
| Q4 24 | $7.3M | $4.4M | ||
| Q3 24 | $-37.1M | $7.0M | ||
| Q2 24 | $-52.4M | $7.2M | ||
| Q1 24 | $-36.8M | $8.0M |
毛利率NKTRRBB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 72.7% | — | ||
| Q3 24 | 81.6% | — | ||
| Q2 24 | 58.5% | — | ||
| Q1 24 | 60.6% | — |
营业利润率NKTRRBB
| Q4 25 | -126.9% | 39.5% | ||
| Q3 25 | -268.6% | 40.7% | ||
| Q2 25 | -324.2% | 36.1% | ||
| Q1 25 | -425.8% | 11.2% | ||
| Q4 24 | 49.2% | 17.6% | ||
| Q3 24 | -142.4% | 31.6% | ||
| Q2 24 | -211.9% | 35.6% | ||
| Q1 24 | -163.7% | 39.9% |
净利率NKTRRBB
| Q4 25 | -165.4% | 31.5% | ||
| Q3 25 | -301.3% | 31.2% | ||
| Q2 25 | -372.2% | 26.1% | ||
| Q1 25 | -486.4% | 8.0% | ||
| Q4 24 | 24.9% | 15.3% | ||
| Q3 24 | -153.6% | 23.1% | ||
| Q2 24 | -222.9% | 26.4% | ||
| Q1 24 | -170.1% | 28.4% |
每股收益（稀释后）NKTRRBB
| Q4 25 | $-4.67 | $0.59 | ||
| Q3 25 | $-1.87 | $0.59 | ||
| Q2 25 | $-2.95 | $0.52 | ||
| Q1 25 | $-0.24 | $0.13 | ||
| Q4 24 | $-2.07 | $0.26 | ||
| Q3 24 | $-2.66 | $0.39 | ||
| Q2 24 | $-3.76 | $0.39 | ||
| Q1 24 | $-0.19 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.1M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $89.8M | $523.4M |
| 总资产 | $280.4M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资NKTRRBB
| Q4 25 | $15.1M | $212.3M | ||
| Q3 25 | $41.0M | $234.9M | ||
| Q2 25 | $43.0M | $191.9M | ||
| Q1 25 | $38.9M | $238.8M | ||
| Q4 24 | $44.3M | $257.7M | ||
| Q3 24 | $30.1M | $349.4M | ||
| Q2 24 | $27.9M | $252.8M | ||
| Q1 24 | $48.6M | — |
总债务NKTRRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益NKTRRBB
| Q4 25 | $89.8M | $523.4M | ||
| Q3 25 | $85.1M | $514.3M | ||
| Q2 25 | $-24.2M | $517.7M | ||
| Q1 25 | $13.7M | $510.3M | ||
| Q4 24 | $60.7M | $507.9M | ||
| Q3 24 | $48.9M | $509.7M | ||
| Q2 24 | $79.7M | $511.3M | ||
| Q1 24 | $126.7M | $514.0M |
总资产NKTRRBB
| Q4 25 | $280.4M | $4.2B | ||
| Q3 25 | $301.3M | $4.2B | ||
| Q2 25 | $207.5M | $4.1B | ||
| Q1 25 | $256.2M | $4.0B | ||
| Q4 24 | $303.9M | $4.0B | ||
| Q3 24 | $308.0M | $4.0B | ||
| Q2 24 | $343.3M | $3.9B | ||
| Q1 24 | $396.0M | $3.9B |
负债/权益比NKTRRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-65.0M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-65.0M | $42.6M |
| 自由现金流率自由现金流/营收 | -298.0% | 131.8% |
| 资本支出强度资本支出/营收 | 0.1% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-208.7M | $73.5M |
8季度趋势，按日历期对齐
经营现金流NKTRRBB
| Q4 25 | $-65.0M | $43.4M | ||
| Q3 25 | $-48.8M | $2.1M | ||
| Q2 25 | $-45.7M | $21.7M | ||
| Q1 25 | $-49.1M | $7.8M | ||
| Q4 24 | $-46.2M | $58.5M | ||
| Q3 24 | $-43.9M | $24.5M | ||
| Q2 24 | $-37.7M | $11.7M | ||
| Q1 24 | $-47.9M | $4.8M |
自由现金流NKTRRBB
| Q4 25 | $-65.0M | $42.6M | ||
| Q3 25 | $-48.9M | $1.8M | ||
| Q2 25 | $-45.8M | $21.6M | ||
| Q1 25 | $-49.1M | $7.6M | ||
| Q4 24 | $-46.6M | $57.7M | ||
| Q3 24 | $-44.6M | $24.2M | ||
| Q2 24 | $-37.9M | $11.5M | ||
| Q1 24 | $-48.0M | $4.7M |
自由现金流率NKTRRBB
| Q4 25 | -298.0% | 131.8% | ||
| Q3 25 | -414.5% | 5.4% | ||
| Q2 25 | -409.6% | 60.2% | ||
| Q1 25 | -469.0% | 26.7% | ||
| Q4 24 | -159.9% | 201.0% | ||
| Q3 24 | -184.9% | 80.0% | ||
| Q2 24 | -161.3% | 42.0% | ||
| Q1 24 | -222.0% | 16.6% |
资本支出强度NKTRRBB
| Q4 25 | 0.1% | 2.5% | ||
| Q3 25 | 1.0% | 1.1% | ||
| Q2 25 | 0.3% | 0.3% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 1.6% | 2.7% | ||
| Q3 24 | 2.8% | 0.8% | ||
| Q2 24 | 0.8% | 0.5% | ||
| Q1 24 | 0.7% | 0.5% |
现金转化率NKTRRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | -6.36× | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
